chemicals

Chemical manufacturer forecasts largest segment earnings will nearly double year-over-year, signaling confidence in end-market demand recovery and pricing power.

The German chemical giant explored a transaction with Evonik this year, but near-term consolidation is unlikely as BASF prepares its agricultural unit for a mid-2027 public offering.

Dow Inc. trades at a 27% P/E discount to peers with consensus forecasting $0.78 per share earnings growth of 510% in the quarter, but one analyst cut price target to $35 from $41.